Skip to main content

Effect of biological therapies on TB treatment outcomes

Buy Article:

$34.78 + tax (Refund Policy)

No Abstract

Document Type: Letter to the Editor

Affiliations: 1: Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia, Servicio de Infectología, Departamento de Medicina Interna, Fundación Valle del Lili, Cali, Colombia, Universidad de Barcelona, Barcelona, Spain 2: Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia 3: Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia 4: Foundation of the Tuberculosis Research Unit of Barcelona, Barcelona, Spain 5: Hospital Clinic, Institut d´Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain

Publication date: November 1, 2022

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content